Table 6.

HT for patients with palliation. Summary of articles reviewed.

Author	Article Type	Investigation	Total Participants	Survival Outcome
Jones et al., 2005 [77]	Phase II RCT	RT + HT vs. RT alone in superficial skin tumours	N = 108	Improved CR. No OS benefit.
Pang et al., 2017 [78]	Phase II RCT	mEHT + TCM vs. IPCI in PCMA	N = 260	Higher ORR. Improved QoL.
Kilmanov et al., 2018 [79]	Phase II RCT	HT + CT vs. CT alone in breast cancer and liver metastases	N = 103	Higher PR and SD. Improved QoL. Longer median time to progression.
Chi et al., 2018 [80]	Phase III RCT	RT + HT vs. RT alone in painful bone metastases	N = 108	Improved pain response. Longer time to pain progression. Improved 1-month QoL.